See feature articles below:
About Broad Street Alerts:
Big opportunities in Small Cap’s
Broad Street Alerts recent profiles and track record, 217% in verifiable potential gains for our members on the last 4 small cap alerts alone!
February 10th, 2016- (NASDAQ: BONT) opened $1.65/share hit a high of $3.00/share within 30 days our member potential gains- 83%
March 7th, 2016-(NYSE-MKT: FSI) opened at .91/share and hit 1.10/share within 5 days for gains of 21% for our members.
March 24th, 2016- (NASDAQ: ICLD) opened at $.77/share it a high of $1.15/share within 2 days for gains of 49% for our members.
April 11th, 2016 – (NASDAQ: FNJN) called at $1.07/share hit $1.76/share in 3 days for 64% gains for our members.
These are numbers that make traders drool. Any trader in any market would fall all over themselves to see numbers like this. So if you’ve been on the fence, perhaps it’s time to start doing some research and verify our numbers for yourself. We are constantly raising the bar and separate ourselves from the rest of the small-cap newsletters as the best in business.
We know with a large following comes a large responsibility as we have everyone from institutional investors to the beginner following our profiled securities in our newsletters. This is something we take very seriously always seeking small cap growth companies that have both near and long-term potential for our members.
***Get our small cap profiles, special situation and watch alerts in real time. We are now offering our VIP SMS/text alert service for free, simply text the word “Alerts” to the phone number 25827 from your cell phone.
Full Report (OTCMKT: PMCB)
The stock of PHARMACYTE BIOTECH INCORPORATED (OTCMKTS:PMCB) registered a decrease of 60.9% in short interest. PMCB’s total short interest was 33,900 shares in April as published by FINRA. Its down 60.9% from 86,700 shares, reported previously. The stock decreased 7.75% or $0.0057 during the last trading session, hitting $0.0683. About 1.41M shares traded hands or 16.53% up from the average. Pharmacyte Biotech Inc (OTCMKTS:PMCB) has declined 22.22% since September 8, 2015 and is downtrending. It has underperformed by 29.54% the S&P500.
Pharmacyte biotech, Inc., formerly Nuvilex, Inc. is a clinical-stage biotechnology company. The company has a market cap of $50.20 million. The Firm focuses on developing and preparing to commercialize treatments for cancer and diabetes based upon a cellulose live cell encapsulation technology known as Cell-in-a-Box. It currently has negative earnings. The Firm uses this technology as a platform upon which treatments for several types of cancer, including advanced, inoperable pancreatic cancer, and diabetes are developed.
Sorce Riverside Gazette
Full Report (OTCMKT: CGRA)
CGrowth Capital Inc (OTCMKTS:CGRA) has lit up the charts and become a microcap runner on the OTC markets. This comes as the company makes the transition from mining to becoming a cannabis operation in the great state of Washington. Pot stocks in general have caught fire as investors are banking on a new Green Rush in 2016.
We’ve been talking about a new Green Rush ever since 2016 rolled around. Roughly 14 states could legalize marijuana this year, adult-use cannabis or possibly both, either at the ballot box or through state legislatures. While it’s doubtful all those states will be successful, there’s a good chance at least a handful will legalize in 2016. No other single year has offered such incredible promise in terms of the sheer volume of states that could legalize, thanks to other pioneering marijuana markets and growing support for cannabis in general.
The ArcView Group just reported that legal sales of cannabis grew to $5.4 billion in 2015, up from $4.6 billion in 2014. Demand is expected to remain strong this year and the research firm forecasts sales of $6.7 billion. Nonmedicinal adult use accounted for $998 million of the total sales in 2015, up from $351 million in 2014, according to the ArcView/New Frontier report summary.
The most surprising aspect for us at Insider Financial is the fact that marijuana stocks have underperformed the major market indices. This sector is probably the fastest-growing industry in America right now and most of the public companies in the space are trading for pennies. With the potential interest coming from all walks of life, we think you’ll see bottom fishers looking for a place to invest.
Pot stocks got active last month after GW Pharmaceuticals plc (NASDAQ:GWPH) reported a successful phase three clinical trial that proved its drug Epidiolex significantly reduced seizures in children with Dravet Syndrome. This news created momentum across the entire marijuana spectrum. Investors see the potential for cannabis-based drugs to replace addictive pills like Oxycodone. Many are now seeing the bigger picture with cannabis and that it’s not just for recreational use, but can also treat diseases. This will lead to more widespread acceptance and get not only Wall Street behind pot stocks, but the regulatory environment in Washington DC as well. These two factors will send pot stocks exploding up the charts.
CGRA has sought to capitalize on cannabis in Washington state. Last week, the company received a Determination of Non-Significance (“DNS”) from Stevens County regarding the company’s application to allow its Eastern Washington industrial facility to transition from a mineral processing site to one that can grow and process cannabis. The effect of the DNS clears the way for the company to proceed with its plans to lease portions or all of its 47-acre site to company’s legally producing and/or processing cannabis and its byproducts in the state of Washington.
The company previously announced an initial lease to Wildfire Cannabis Company (“Wildfire”), a Tier 3 cannabis operation. Under its license, Wildfire is qualified to manage up to 30,000 square feet of plant production. The company is in the process of providing Wildfire its initial turnkey building space, with the objective of fulfilling the entire 30,000 square feet, plus a separate processing facility.
CGRA has also executed a 5-year lease to provide an approved F-1 manufacturing facility for legalized cannabis production and processing to two (2) additional I-502 Tier 3 cannabis producer/processors at its Washington state facility. The tenants, “Randolph and Mortimer” and “Wonder West Group,” join the previously announced Wildfire Cannabis Company at the site to bring the total lessees to three.
A licensed Tier 3 marijuana producer is currently qualified to manage between 10,000 square feet to 30,000 square feet of marijuana grow canopy, as well as additional processing within Washington State (the largest available license). The combined tenant production that the company now supports is as much as 90,000 square feet of marijuana grow canopy at full capacity.
Currently trading with a market cap of $6.59 million, CGRA has also issued bonds in the amount of £7,300,000.00 GBP. The bonds subscribed include £4,100,000.00 GBP in cash (or ~$ 5,700,000.00 USD gross proceeds), a note receivable in the amount of £1,900,000.00 GBP, and equity in the amount of £1,300,000.00 GBP. Funding from the bond subscriptions are being used to finance the three (3) bond projects, including the company’s Powder River basin oil and gas project in Wyoming. The company’s subsidiary, Powder River Resources, Inc.’s proven and probable oil reserves, which management estimates to be $250,000,000.00, is the focus of the funding. Powder River Resources, Inc. and CGrowth Capital Bond Ltd. have an umbrella policy of $10,000,000.00 covering the project. We will be updating Insider Financial as soon as we know more. For continuing coverage on CGRA, sign up for our free newsletter today and get our next hot stock pick!
Source: Insider Financial
Full Report (OTCMKT: TRTC)
Terra Tech Corp (OTCMKTS:TRTC) Director Mike Vandevrede sold 100,000 shares of the company’s stock in a transaction that occurred on Tuesday, April 12th. The stock was sold at an average price of $0.37, for a total value of $37,000.00. Following the sale, the director now directly owns 1,056,944 shares of the company’s stock, valued at approximately $391,069.28. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website.
Shares of Terra Tech Corp (OTCMKTS:TRTC) opened at 0.472 on Monday. Terra Tech Corp has a 12 month low of $0.08 and a 12 month high of $0.49. The firm’s 50-day moving average price is $0.25 and its 200-day moving average price is $0.15. The company’s market cap is $134.70 million.
Terra Tech Corp. is a holding company. The Company has three wholly owned subsidiaries, GrowOp Technology Ltd., Edible Garden Corp. and IVXX, LLC. The Company also has ownership interests in MediFarm, MediFarm I and MediFarm II. The Company, through its wholly owned subsidiary, GrowOp Technology Ltd.
Source: WEB Breaking News
Full Report (NYSE: SUNE)
In a filing with the U.S. Securities and Exchange Commission (SEC) Friday morning, SunEdison Inc. (NYSE: SUNE) said it has entered into confidentiality agreements with certain of its first- and second-lien lenders related to proposed debtor-in-possession financing for the struggling solar PV maker. As part of the agreement, SunEdison filed a copy of a presentation it made to second-lien lenders on March 17, 2016, less than two weeks following the company’s termination of its deal to acquire Vivint Solar Inc. (NYSE: VSLR).
The presentation filed Friday morning identifies three key goals for SunEdison:
Maximize value for all SunEdison stakeholders.
Move through the process as quickly as possible to maximize value and future growth potential.
Focus on core regions (North America, India, Latin America) while growth regions are on “hot idle” until liquidity improves.
To meet these goals the company specified four key enablers:
Achieve $310 million of financing.
Realize relief from select obligations, including earn-outs.
Monetize residential and small commercial business unit.
Reduce operating costs to $400 million or less.
To achieve its goal of $310 million the company would pledge all the assets it had already used to secure its first- and second-lien loans, and virtually every other asset the company had:
All assets pledged by subsidiaries that own various operating projects
All assets pledged by subsidiaries that own various projects being sold
All assets pledged by subsidiaries that own various projects under development
Assets of the Residential Services business
Unencumbered real estate
This and the accompanying presentation slides look to us as though they form the basis for a debtor-in-possession financing package that gives SunEdison a path to stay in business for the rest of this year. SunEdison would maintain both its yieldcos, TerraForm Power Inc. (NASDAQ: TERP) and TerraForm Global Inc. (NASDAQ: GLBL), sell its residential and small commericial business, shift its focus to selling projects at full-notice to proceed (FNTP) and consolidate operations to drive efficiency. Cash flow at the end of 2016 is projected at $259 million under this scenario.
The full presentation was filed as Exhibit 99.1 with the Form 8-K.
The company’s stock is getting battered again, down about 34% at $0.39 shortly before noon on Friday. The stock’s 52-week range is $0.20 to $33.45.
Source: 24/7 Walls St
Broad street alerts has not been compensated for the mention of any publicly traded companies in this article with exception to FNJN.
Broad Street Alerts was previously compensated eighteen thousand five hundred dollars by star media llc for the mention of FNJN however, that contract has expired.